How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

Title
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Authors
Keywords
Sentinel Node, Sentinel Lymph Node Biopsy, Axillary Lymph Node Dissection, Axillary Dissection, Pertuzumab
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 23, Issue 11, Pages 3467-3474
Publisher
Springer Nature
Online
2016-05-10
DOI
10.1245/s10434-016-5246-8

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now